🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join this webinar featuring early-career scientists discussing recent advancements in the pharmacology of equilibrate nucleoside transporter 1, its role in decitabine-induced myelotoxicity and more! Learn more and register here: bit.ly/3nGodfw. #pharmacology

Mark your calendars for a presentation by Dr. David Sibley at the 2025 Norman Weiner Lecture. During this online lecture, he will discuss identifying novel modulators or targeting dopaminergic signaling. Register here: ow.ly/HJaR50VU4M2 #pharmacology

Kerim Cakir, PhD student at Temple University School of Pharmacy, is the June 2025 HTA for JPET. Kerim’s research focuses on the current complication in the fentanyl supply in our community which is the introduction of alpha-2-agonists such as xylazine. 🔗Read here: doi.org/10.1016/j.jpet…

Enter our Journals Cover Contest to see your image featured on a 2026 ASPET journal cover for a full year! ASPET will select five winning images, and each winning entry will be awarded $250.00. Entries due on August 15. See contest rules: ow.ly/4g1B50W3Jw0. #pharmacology

ASPET's Government Affairs team is on Capitol Hill today with the Coalition for Health Funding, advocating for funding for science and health.

Nina Beltran was interested in gaining a deeper understanding of science policy and how it impacted biomedical research and drug development. If you want to expand your skills and career opportunities in science policy, apply by June 30: ow.ly/zyLw50VTiwu. #pharmacology

ASPET’s JPET (ASPET) and @PhRMAFoundation are partnering on a Challenge Award competition—a prize of $5,000—for outstanding papers addressing the #pharmacology of next generation therapeutics! 📆Submit by July 1, 2025. 🔗Learn more: phrmafoundation.org/grants-fellows…

Xingyu Zhu, a PhD candidate at NUS is the June 2025 Highlighted Trainee Author for DMD. Her research focuses on understanding how certain genetic differences in our DNA can influence heart rhythm and affect how individuals respond to medications: doi.org/10.1016/j.dmd.…

Today, over 300 NIH staff wrote a letter urging Director Jayanta Bhattacharya to reject policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe. ✒️ Add your voice and sign the letter: standupforscience.net/bethesda-decla….

Molecules targeting misfolded proteins through autophagy in #neurodegenerative diseases show promise for treatment! #PharmRev #Alzheimers #Parkinsons #ALS Read the article here: doi.org/10.1016/j.phar…

Join this webinar featuring early-career scientists discussing recent advancements in the pharmacology of equilibrate nucleoside transporter 1, its role in decitabine-induced myelotoxicity and more! Learn more and register here: bit.ly/3nGodfw. #pharmacology

Meet the early career scientists—Mia Allen, Ankit Balhara and Joy Li—who have been highlighted in the May 2025 issue of The Pharmacologist. They share what motivates them, the significance of their research and how they hope it'll advance pharmacology. 🔗 thepharmacologist.org/on-their-way-m…

Join today's webinar featuring early-career scientists discussing recent advancements in the pharmacology of equilibrate nucleoside transporter 1, its role in decitabine-induced myelotoxicity and more! Learn more and register here: bit.ly/3nGodfw. #pharmacology

Enter our Journals Cover Contest to see your image featured on a 2026 ASPET journal cover for a full year! ASPET will select five winning images, and each winning entry will be awarded $250.00. Entries due on August 15. See contest rules: ow.ly/4g1B50W3Jw0. #pharmacology

ASPET is in Chicago, IL, and we are happy to support the Great Lakes Chapter at its 2025 GLC ASPET 38th Annual Meeting!

Pericytes are emerging as key players in Alzheimer’s disease, regulating blood-brain barrier integrity, blood flow, and amyloid clearance. Check out this exciting new PharmRev publication highlighting this promising therapeutic target: doi.org/10.1016/j.phar…

An old dog with many new tricks! Check out to learn recent preclinical and clinical evidence that underscores the potential of Cytochrome P450 (CYP) 1B1 as a therapeutic target: doi.org/10.1016/j.phar….

📢Two weeks left — Early-career researchers, submit your research today! JPET and @PhRMAFoundation are partnering on a Challenge Award competition for outstanding papers addressing the #pharmacology of next gen therapeutics. 📆 Deadline: July 1, 2025 🔗 phrmafoundation.org/grants-fellows…

If you’re interested in exploring a potential career in science policy and advocacy, then you should apply for the 2025-2026 ASPET Washington Fellows program! There’s still time to submit your application. Apply by June 30, 2025. 🔗Learn more here: aspet.org/aspet/advocacy….

Mark your calendars for a presentation by Dr. David Sibley at the 2025 Norman Weiner Lecture. During this online lecture, he will discuss identifying novel modulators or targeting dopaminergic signaling. Register here: ow.ly/HJaR50VU4M2 #pharmacology